Recipharm Revenue and Competitors
Estimated Revenue & Valuation
- Recipharm's estimated annual revenue is currently $916.2M per year.
- Recipharm's estimated revenue per employee is $277,540
- Recipharm's total funding is $149M.
Employee Data
- Recipharm has 3301 Employees.
- Recipharm grew their employee count by -5% last year.
Recipharm's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | CFO - Member the Executive Committee | Reveal Email/Phone |
7 | Group General Counsel, Chief Compliance Officer, ESG Head, Board Secretary | Reveal Email/Phone |
8 | Chief Information Officer (CIO) | Reveal Email/Phone |
9 | Head Supply Chain | Reveal Email/Phone |
10 | VP & Site Director | Reveal Email/Phone |
Recipharm Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.6M | 56 | 0% | $6.3M | N/A |
What Is Recipharm?
Recipharm is your partner for contract pharmaceutical development and manufacturing. With production facilities across Europe, we are uniquely positioned to deliver reliable and flexible service for all our customers, wherever you are. We supply several hundred different products in a variety of dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder inhalers and granulates, from our various facilities across Europe. Recipharm’s Pharmaceutical Development Services group activities a range from straight forward clinical supply through to more complex product development and formulation. From our pharmaceutical development centre we can work on a variety of technologies (including sterile products). Formulation Development, Clinical Supplies, Analytical Development, Stability Studies, Packaging Development and Raw Material Selection are all core activities. Pharmaceutical contract development and manufacturing
keywords:N/A
$149M
Total Funding
3301
Number of Employees
$916.2M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Recipharm News
CMO/CDMO Market Set to Witness Explosive Growth by 2029 | Recipharm, AMRI3, Patheon · New Jersey, N.J. · Get the PDF Sample Copy (Including FULL...
CMO/CDMO Market Set to Witness Explosive Growth by 2029 | Recipharm, AMRI3, Patheon · New Jersey, N.J. · Get the PDF Sample Copy (Including FULL...
Recipharm entered the biologics market earlier this year with the acquisition of GenIbet, a Portuguese biopharmaceutical contract manufacturing...
Recipharm entered the biologics market earlier this year with the acquisition of GenIbet, a Portuguese biopharmaceutical contract manufacturing...
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $535.3M | 3446 | 5% | $7M |
#2 | $12980M | 5376 | 5% | N/A |
#3 | $1775.2M | 8745 | N/A | N/A |
#4 | $8550.7M | 22621 | 4% | N/A |
#5 | $4980M | 28082 | 4% | N/A |